Reopening America

Latest Episodes:

U.S. Pays Pfizer, BioNTech $1.95 Billion to Secure Millions of COVID-19 Vaccine Doses Jul 23, 2020

Show notes

The U.S. has agreed to pay Pfizer and BioNTech nearly $2 billion to secure 100 million doses of their experimental coronavirus vaccine. It still needs to go through phase three trials and be approved by the FDA, but the race is on to secure as many doses as possible. Operation Warp Speed has struck similar deals with other vaccine developers as well. Jared Hopkins, Pharma reporter at the WSJ, joins us for all the money being poured into vaccines.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

After Months of Coronavirus Restrictions Many Restaurants Are Calling It Quits Jul 22, 2020

Show notes

Many restaurants have hit their breaking point and are permanently calling it quits. Riding the rollercoaster of coronavirus restrictions and people wary of eating out has proved too much for some to stay in business. Over 15,000 restaurants have permanently closed and more could be on the way. Heather Haddon, reporter at the WSJ, joins us for how the pandemic continues to wreak havoc on the restaurant industry.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

Vitamin C Is Having a Moment During the Pandemic but Watch Out for Fake COVID-19 Treatments Jul 22, 2020

Show notes

Vitamin C is a having a moment during the pandemic and sales are surging, but you have to watch out for some offering it up as a coronavirus treatment. The FTC and FBI are investigating health clinics and wellness centers for overhyping high-dose IV infusions of vitamin C as ways to prevent or treat COVID-19. Brent Schrotenboer, investigative reporter at USA Today, joins us for more.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

Oxford Coronavirus Vaccine Is Safe and Triggers Immune Response Jul 21, 2020

Show notes

Good news on the vaccine front: In early stage trials, a vaccine candidate from Oxford University and AstraZeneca caused no serious side effects and produces an immune response of both antibodies and T-cells. The U.S. has also paid $1.2 billion dollars to secure at least 300 million doses when it’s available. Dave Lawler, world editor at Axios, joins us for the latest on the Oxford vaccine.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

Pandemic Wage and Hour Cuts Could Become Permanent If Crisis Persists Jul 21, 2020

Show notes

When looking at the economic toll the pandemic has inflicted on the country, many people are focused on job losses and unemployment benefits, but another thing to look out for is wage cuts. Many Americans who kept their jobs have seen temporary hour and pay cuts that could become permanent or pave the way for more layoffs. Megan Cassella, economics reporter at Politico, joins us for these widespread wage cuts.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

In the Fight Against Coronavirus, It's Every State for Themselves Jul 20, 2020

Show notes

From the beginning of the pandemic and despite calls from governors across the country for a unified national response, the plan has largely been every state for itself. From obtaining your own PPE and setting up your own testing and contact tracing programs, states have been desperate for federal support. Alice Miranda Ollstein, healthcare reporter at Politico, joins us for more.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

End Game for COVID-19 Is Herd Immunity, but the Math to Get There Is Tricky Jul 20, 2020

Show notes

We are all looking forward to the end game for COVID-19, when the spread of the virus slows down significantly or stops altogether because enough people have immunity to it. Whether it is by vaccine or enough people catching it, we are trying to get to the point of herd immunity, but the math to get there is tricky, and the variables used to calculate keep making it a moving target. Kevin Hartnett, senior math writer at Quanta Magazine, joins us for how the population can achieve herd immunity.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

The Conversation of Sports Players Getting COVID Testing Continues Jul 17, 2020

Show notes

Demand for coronavirus testing continues to go up and the supplies continue dwindle, as we hear stories of long wait times and even longer waits for results. But that doesn’t seem to be a problem for sports teams that are testing players every day and getting results in 24 hours. Louise Radnofsky, sports reporter at the WSJ, joins us for how sports teams are handling testing.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

Are Those Stories of Coronavirus Parties Real? Jul 17, 2020

Show notes

COVID parties are not a thing. You might have seen stories about people throwing parties to intentionally infect others with the coronavirus, but if you dig deeper into the stories, they quickly fall apart. To be clear, people can and are getting sick by partying in close quarters, but they are not throwing COVID-specific parties. Gilad Edelman, senior writer at Wired, joins us for more.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

Arizona Didn't Prepare When Coronavirus Cases Were Low and Is Now One of the U.S. Hotspots Jul 16, 2020

Show notes

We’ve seen a number of states experience a surge in coronavirus cases and become new hotspots. Largely avoiding a big outbreak early in the pandemic, Arizona now has the highest per-capita rate of COVID-19 cases in America over the past week. Local officials and public health experts are pointing a finger at the leadership for being complacent and not preparing for a future wave when they had time. Dan Frosch, reporter for the WSJ, joins us for how Arizona wasn’t ready for its coronavirus surge.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected